𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neoadjuvant treatment of HER2 overexpressing primary breast cancer with trastuzumab given concomitantly to epirubicin/ cyclophosphamide followed by docetaxel ± capecitabine. First analysis of efficacy and safety of the GBG/AGO multicenter intergroup-study “GeparQuattro”

✍ Scribed by M. Untch; M. Rezai; S. Loibl; P.A. Fasching; J. Huober; H. Tesch; I. Bauerfeind; J. Hilfrich; K. Mehta; G. von Minckwitz

Book ID
119597808
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
60 KB
Volume
6
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cardiac safety analysis of the first sta
Cardiac safety analysis of the first stage of NSABP B-31, a randomized trial comparing the safety and efficacy of doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) to that of AC followed by paclitaxel plus trastuzumab (TH) in patients (pts) with operable, node-positive (N+), HER-2 overexpressing breast cancer (HER2+BC)
✍ C Geyer; J Bryant; E Romond; E Tan-Chiu; M Ewer; D Keefe; R Shannon; G Yothers; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 541 KB